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Abstract
Adipocytes and perivascular adipose tissue are emerging to regulate vascular 
functions. Effects of adipocytes and perivascular adipose tissue on human smooth 
muscle cell (SMC) proliferation were investigated. Conditioned medium was prepared 
from cultured premature and differentiated 3T3-L1 adipocytes, from peri-aortic 
adipose tissue from young (3 months) and old (24 months) WKY rats, from lean and 
obese Zucker rats (3 months), and from WKY rats fed normal chow or a high fat diet 
for 3 months. Conditioned medium from differentiated (but not premature) adipocytes 
stimulated SMC proliferation, which was abolished by charcoal and proteinase K 
treatment, but resistant to heat, trypsin or phospholipase B (to hydrolyze 
lysophosphatidic acid). Further experiments demonstrated that the growth factor(s) is 
hydrosoluble, present in the fraction of molecular weight >100 kDa. Moreover, 
conditioned medium from peri-aortic adipose tissue stimulated SMC proliferation, 
which was significantly enhanced in aged rats and in rats fed high fat diet, but not in 
obese Zucker rats deficient in leptin receptor. In conclusion, mature adipocytes 
release a hydrosoluble protein growth factor(s) with molecular weight >100 kDa for 
SMC. Perivascular adipose tissue stimulates SMC proliferation, which is enhanced in 
aged WKY and in high fat diet-induced obesity but not in leptin receptor deficient 
obese Zucker rats. This adipocyte-derived growth factor(s) and the effect of 
perivascular adipose tissue may be involved in vascular disease associated with aging 
and obesity. 
Keywords: Aging - cardiovascular disease - growth substances – obesity – risk 
factors
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The pathogenesis of coronary artery disease and its complications is 
multifactorial, involving vasoconstriction, thromboembolism and vascular smooth 
muscle cell (SMC) proliferation (30). Risk factors such as aging, obesity, diabetes 
mellitus and dyslipidemia, adversely regulate the disease process (2; 33). Recent 
studies using co-culture or conditioned media techniques demonstrate that adipocytes 
are highly active in secretion of hormonal substances (6; 9; 14; 17) which play 
important roles in modulating vascular functions. In addition to angiotensin II (32) 
and plasminogen activator inhibitor-1 (25), potential factors in vasoconstriction and 
thromboembolism, adipocytes also produce hormones regulating SMC proliferation 
including growth promoters such as tumor necrosis factor-DTNFD, leptin, fibroblast 
growth factor (FGF), insulin-like growth factor (IGF), transforming growth factor 
E(TGFE and heparin binding-epidermal growth factor (HB-EGF)(23; 26; 31), and 
the growth inhibitor adiponectin (22). In addition, adipocytes also release the 
phospholipid growth promoter lysophosphatidic acid (LPA) (12; 27). Although the 
effects of the individual factors on SMC proliferation are well documented, direct 
effects of adipocytes on SMC proliferation have not been thoroughly investigated yet. 
The list of vasoactive factors released from adipocytes is growing (11). A novel yet to 
be identified vascular relaxing factor(s) released from peri-vascular fat tissue has been 
recently proposed (18; 36), suggesting that perivascular adipose tissue, whose 
function is usually ignored in vascular biology studies, may play a role in modulation 
of vascular functions. Therefore, the present study was designed to investigate the 
direct effects of adipocytes and perivascular adipose tissue on SMC proliferation and 
the influence of aging and obesity. 
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Materials and Methods 
Materials: Bovine insulin, bovine serum albumin (BSA), indomethacin, 
phospholipase B, and all other chemicals were purchased from Sigma (Buchs, 
Switzerland). Proteinase K was from Roche (Rotkreuz, Switzerland); 3-isobutyl-1-
methylxanthine (IBMX) and dexamethasone were from Calbiochem (Lucerne, 
Switzerland); rabbit polyclonal anti-phospho-(Thr202/Tyr204) p42/44mapk and anti-
p42/44mapk antibodies were purchased from Cell Signaling Technology (Allschwil, 
Switzerland); anti-rabbit IgG alkaline phosphatase (AP) conjugate and Western 
BlueTM stabilized substrate for AP were from Promega (Wallisellen, Switzerland); 
Fetal calf serum (FCS), Media for SMC culture were purchased from Bioconcept 
(Allschwil, Switzerland) and media for murine 3T3-L1 adipocytes (ATCC, LGC 
Promochem, Molsheim, France) were from Gibco (Basel, Switzerland). 
Adipocyte culture and differentiation: Murine 3T3-L1 preadipocytes were cultured 
and differentiated in DMEM media with 10% FCS as described (19). 
Preparation of adipocyte-conditioned medium (ACCM): Conditioned medium 
from preadipocytes and differentiated adipocytes were prepared as following: 
confluent cells were washed and kept in serum-free DMEM/F-12 with 0.2% BSA 
without any growth factors (110 Plmedium/cm2) for 24 hours. The conditioned 
medium was collected and centrifuged (13’000 rpm, 10 minutes, and 4°C) to remove 
cell debris. To analyse whether prostaglandins are involved in stimulation of SMC 
growth, the adipocytes were treated with the cyclooxygenase inhibitor indomethacin 
(1 Pmol/L) during the 24-hour conditioning. To characterize the chemical features of 
growth factor(s) released by the adipocytes, the adipocyte-conditioned medium was 
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treated with trypsin (2 Pg/ml) at 37°C for 2 hours and/or heated at 65°C for 10 
minutes, or treated with proteinase K (10 Pg/ml, 37°C, 2 hours) and then heated at 
90°C for 30 minutes, a condition which is required to inactivate the enzyme. The 
effect of heating at the temperature of 90°C on the biological activity of ACCM was 
also independently tested. In another series of experiments, ACCM was treated with 
activated charcoal (10%) for 1 hour. The charcoal was then removed by centrifugation 
at 13’000 rpm for 10 minutes followed by filtration through a filter paper with a pore 
size of 0.22 Pm. To estimate molecular weight of the growth factor(s), trypsinized and 
heated ACCM was subjected to molecular size sieving using an Amicon ultrafiltration 
device fitted with a membrane with molecular weight cut-off at 100 kDa (Ultrafree-
0.5 centrifugal filter device, Millipore). Both the concentrate and filtrate reconstituted 
to the initial volume with Ham/F12 culture medium were assayed for their biological 
activity. These experiments showed that the growth promoting effect of ACCM was 
mainly present in the concentrate. The trypsinized, heated and ultrafiltered 
concentrate was then subjected to saturated butanol to separate liposoluble and 
hydrosoluble fractions.
SMC culture: SMC were cultured from human saphenous veins (passages 6 to 14) or 
from human aorta (passages 9 to 11) as previously described (39).
 SMC proliferation: SMC were distributed in 96 well plates at an initial density of 
2x103 cells per well and allowed to attach overnight. The cells were rendered 
quiescent in serum-free DMEM with 0.2% BSA for 48 hours (38; 39) and then 
incubated with ACCM at different dilutions for 48 hours. Cell proliferation was 
measured using the Celltiter 96 Aqueous One Solution Proliferation Assay Kit 
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(Promega) according to the manufacturer’s instructions, or by counting the cell 
number over 8 days. The cells were stimulated with conditioned medium (100 Pl/ml) 
every other day. Each measurement was performed in duplicate. 
p42/44mapk activation: The quiescent SMC were stimulated with adipocyte 
conditioned medium (100 Pl/ml) for indicated times, and p42/44mapk activation 
(phosphorylation at Thr202/Tyr204) was measured as described(38). Protein 
concentration was determined by Bio-Rad DC protein assay kit. Quantification of the 
signals was performed by NIH Image 1.62 software. 
Animals and preparation of perivascular adipose tissue conditioned medium 
(ATCM). Three young (3 months) and three old (24 months) male WKY rats, and 
three obese Zucker fa/fa and three lean Zucker fa/+ rats (male, 3 month old) were fed 
normal chow. All rats were purchased from Harlan Netherlands. In addition, three 
male WKY rats (3 months) were fed a high fat diet (60 cal % of energy as fat, 
Provimi Kliba AG, Kaiseraugst, Switzerland) for a period of 3 months, and three age 
and sex matched WKY rats were fed normal chow during the same time period to 
serve as controls. All animals were maintained according to the local rules of animal 
experimentation. The animals were anesthetized with pentobarbital sodium (50 mg/kg 
body weight, i.p.) and sacrificed. The aortas were removed. Perivascular adipose 
tissue was dissected along the whole aortas and weighed. 400 mg of the fat tissue 
from each animal were collected and conditioned at 37°C in 1 ml of serum-free 
DMEM/F12 medium with 0.2% BSA for 4 or 24 hours. The adipose-tissue-
conditioned medium (ATCM) was centrifuged, frozen and kept at –80°C until use. To 
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characterize the biological activities of ATCM, the medium was treated with trypsin 
or proteinase K and/or heated as described above for ACCM. 
Statistics: Cell proliferation was expressed as % increase above the corresponding 
values of quiescent cells when assayed by the proliferation kit, or as number of cells 
per ml. Data were given as mean±SEM. In all experiments, n equals the number of 
experiments. Statistical analysis was performed by one-way ANOVA Tukey-Kramer 
multiple comparisons test or unpaired Student’s t-test. Differences were considered 
statistically significant at values of p<0.05. 
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Results
Conditioned medium from cultured adipocytes (ACCM) stimulates SMC 
proliferation. 
Conditioned medium from differentiated murine 3T3-L1 adipocytes (ACCM, 2 to 
100 Pl/ml) stimulated human saphenous vein and aortic SMC proliferation in a 
concentration-dependent manner (Fig. 1A and 1B, 206±21% increase in the vein and 
145±9% increase in the aorta at the highest concentration used i.e. 100 Pl/ml, n=5-6, 
p<0.01). Notice that the relative weaker response of the aortic SMC is due to an 
intrinsic weaker proliferative activity of the cell line in general compared to the 
venous SMC, since a weaker proliferative response to 5% fetal calf serum (FCS) was 
also observed in aortic (299±22% increase) compared to venous SMC (425±29%) 
(n=4, p<0.05). Because the higher proliferative activity of venous SMC allows a more 
precise analysis of the functions of adipocytes on SMC proliferation, the following 
experiments were performed in the venous SMC. Our previous studies showed a 
similar growth property between human saphenous vein and coronary artery SMC 
(28; 37; 38).
Interestingly, conditioned medium from premature or undifferentiated adipocytes 
had no effects on SMC proliferation in both saphenous vein and aorta (Fig. 1A and
1B, n=6). The SMC growth promoting effect of the conditioned medium from mature 
adipocytes was not affected by treating the cells with the cyclooxygenase inhibitor 
indomethacin (1 Pmol/L) during the 24-hour conditioning (data not shown). 
Treatment of ACCM by charcoal fully eliminated the growth promoting effect (Fig.
1C).
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Incubation of ACCM with phospholipase B (3 U/ml, 37°C) for 30 minutes to 
hydrolyse lysophosphatidic acid (LPA) released from adipocytes, caused only 33±3% 
inhibition of SMC proliferation (p<0.05, n=14), but a 93±12% inhibition of 
p42/44mapk activation stimulated by ACCM (100 Pl/ml, 10 minutes, p<0.05, n=3). 
Furthermore, SMC proliferation stimulated by ACCM (100 Pl/ml) at 48 hours or the 
increase in cell number stimulated by ACCM (100 Pl/ml) over 8 days remained 
unaffected when the conditioned medium was heated (65oC, 10 minutes) or 
trypsinized (2 Pg/ml, 37oC, 2 hours) (n=3-4; Fig. 2A and 2B), although p42/44mapk 
activation by ACCM (100 Pl/ml, 10 minutes) was inhibited by over 70% by the 
treatments (Fig. 2C).
Despite being resistant to trypsin, ACCM was sensitive to proteinase K treatment. 
The results in figure 2A and 2B showed that heating ACCM at 65oC for 10 minutes 
had no effects on its growth promoting activity. We further showed that heating 
ACCM at a higher temperature i.e. 90°C for 30 minutes (a condition which is required 
to inactivate proteinase K) only slightly reduced its growth promoting effect (22% 
reduction, p<0.05, Fig. 3) further confirming the heat-resistant feature of the growth 
factor(s) contained in the conditioned medium. This heat-resistant component of 
ACCM was, however, abolished by proteinase K treatment (10 Pg/ml, 37°C, 2 hours, 
Fig. 3).
Ultrafiltration of heated and trypsinized ACCM with a membrane with molecular 
weight cut-off at 100 kDa showed that the growth promoting effect was retained in 
the fraction which has a molecular weight >100 kDa (Fig. 4A). The result indicates 
that the active substance(s) released from cultured adipocytes has a molecular weight 
higher than 100 kDa. Furthermore, lipid extraction of heated and trypsinized ACCM 
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with butanol showed that the growth stimulating activity of ACCM was retained in 
the hydrosoluble but not liposoluble fraction (Fig. 4B).
Conditioned medium from peri-vascular adipose tissue stimulates SMC 
proliferation: effects of aging and obesity
The effect of perivascular adipose tissue on SMC growth and impact of aging and 
obesity were further investigated. We showed that adipose tissue conditioned medium 
(ATCM) prepared from peri-aortic fat of 3 month old WKY rats (4 hours 
conditioning) also stimulated SMC proliferation (Fig. 5). In contrast to ACCM, the 
growth stimulating effect of ATCM (100 Pl/ml) was partly sensitive to heat either at 
65°C for 10 minutes (p<0.01, Fig. 5A) or 90°C for 30 minutes (p<0.01, Fig. 5B). It is 
resistant to trypsin (Fig. 5A). Indeed, trypsin treatment of ATCM alone or in 
combination with heat did not affect the growth promoting effect of ATCM (Fig. 5A).
The growth promoting activity of ATCM was, however, further reduced by proteinase 
K treatment (Fig. 5B). Note that a significant portion of the growth promoting activity 
of ATCM was still retained after combined treatment of heat plus trypsin (41%, 
p<0.01 vs. ATCM, Fig. 5A) or heat plus proteinase K (40%, p<0.05 vs. ATCM, Fig. 
5B).
To study aging- and obesity-dependent effect, young (3 months) and old WKY 
rats (24 months) and two obesity animal models namely Zucker fa/fa rats that are 
deficient of leptin receptor and high fat diet-induced obese WKY rats were used. The 
body weight of old (24 month old) and high fat diet fed obese (6 month old) WKY 
rats and that of obese Zucker fa/fa rats (3 month old) were comparable and 
significantly higher when compared to their respective controls (table 1). Although 
the old WKY rats had greater absolute amount of peri-aortic fat tissue than the young 
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rats, the ratio of peri-aortic fat / body weight, however, was comparable between the 
two groups (table 1). Interestingly, the absolute amount of peri-aortic fat tissue and 
the ratio of peri-aortic fat / body weight were higher in the two obesity animal models 
than in the lean littermates (table 1).
Conditioned medium of perivascular adipose tissue (ATCM, 100 Pl/ml) prepared 
from 4-hour conditioning concentration-dependently stimulated SMC proliferation 
(Fig. 6A). This effect was significantly enhanced in aged and high fat diet fed obese 
WKY rats as compared to the young and lean animals, respectively (Fig. 6A and 6B).
In contrast, this effect of peri-aortic adipose tissue was, however, less pronounced in 
obese Zucker fa/fa rats as compared to the lean littermates (Fig. 6C).
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Discussion
Recent research indicates that adipocytes release hormones regulating vascular 
functions including SMC growth (22; 23; 26; 29; 31). In the present study, we showed 
that conditioned medium from differentiated mature adipocytes but not that from 
premature or undifferentiated adipocytes stimulated SMC proliferation, suggesting 
that a growth factor(s) is specifically produced from differentiated adipocytes. In line 
with our results, a recent study by Manabe et al. demonstrated that mature primary 
adipocytes, but not preadipocytes, isolated from subcutaneous fat tissue of Wistar rats 
stimulate breast cancer cell proliferation (20). Our results, however, contrast with an 
early study which showed no growth promoting effect on rat and calf aortic SMC with 
conditioned medium from 3T3-F442A adipocytes (4). The discrepancy might be due 
to the different experimental conditions used such as different adipocytes or SMC 
lines or different dilutions of the preparation of the conditioned medium.   
The chemical nature of the SMC growth factor(s) released from mature 
adipocytes shown in our present study was further investigated. The involvement of 
prostaglandins can be excluded, since conditioned medium from mature adipocytes 
treated with cyclooxygenase inhibitor indomethacin did not affect the growth 
promoting effect. Indomethacin has also been shown to activate PPARJ in 
adipocytes(15). PPARJ activation reduces the release of free fatty acids and 
adipokines mediating insulin resistance such as TNFD, leptin, and resistin, but 
increases SMC growth inhibitor adiponectin production, and PPARJ activation in 
SMC has been reported to cause cell growth arrest (for details, see (21)). As a 
consequence of PPARJ activation, the proliferation of SMC stimulated by adipocyte-
conditioned medium should be inhibited by indomethacin treatment. However, this is 
not the case, suggesting that those factors that are regulated by PPARJ could not be 
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responsible for the growth promoting effect of adipocyte-conditioned medium. The 
factor(s) can be adsorbed by charcoal, since charcoal fully eliminated the growth 
promoting effect of the adipocyte conditioned medium. It is known that adipocytes 
are able to produce oestrogen which promotes breast cancer cell growth (20; 35). 
However, oestrogen can not account for the SMC growth promoting effect, since 
oestrogen does not stimulate, but inhibits SMC proliferation as shown by our previous 
study(7). In addition, adipocytes also produce significant amount of LPA, a lipid 
which has been shown to stimulate SMC growth(12). In our experiments, treatment of 
adipocyte conditioned medium with phospholipase B, the enzyme that hydrolyses 
LPA (10), only partially reduced the growth stimulating effect (33% inhibition), but 
largely attenuated p42/44mapk activation by the conditioned medium (93% 
inhibition). These results suggest that LPA only partially contributes to the observed 
growth stimulating effect.  
The most important finding of our present study is that the growth promoting 
effect of the conditioned medium from mature adipocytes is heat- and trypsin-
resistant, but proteinase K-sensitive (Fig. 2 and Fig. 3), suggesting the proteinous 
nature of the growth factor(s). Further experiments with ultrafiltration demonstrated 
that the growth promoting effect of the adipocyte-conditioned medium was retained in 
the fraction which has a molecular weight >100 kDa (Fig. 4A). Moreover, lipid 
extraction of heated and trypsinized adipocyte-conditioned medium showed that the 
growth promoting effect is present in hydrosoluble fraction (Fig. 4B) suggesting the 
water soluble nature of the growth factor(s). The high molecular weight with the 
feature of trypsin- and heat-resistance might implicate a protein with a globular 
structure.  Note that p42/44mapk activation by the conditioned medium was markedly 
inhibited by trypsin or heating, implicating that other factors which stimulate 
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p42/44mapk were inactivated, and the heat- and trypsin-resistant growth factor(s) 
stimulates SMC proliferation mainly independently of p42/44mapk. It is also to notice 
that heating, trypsin-digestion and phospholipase B treatment all independently 
reduced p42/44mapk activation by over 70%, which may be due to the synergistic 
effects of LPA and other growth factors(8).
Blood vessels are surrounded by adventitial perivascular fat tissue which is 
usually ignored by experiments investigating vascular functions. It is emerging that 
the perivascular adipose tissue may play a role in regulation of vascular functions as 
suggested most recently. Indeed, these studies showed that perivascular adipose tissue 
from rat aortas or mesenteric arteries produces a SMC relaxing factor(s)(18; 36). In 
the present study, we further demonstrated that peri-aortic adipose tissues also release 
growth factor(s) stimulating SMC proliferation (Fig. 5). The chemical features of the 
biological activity of ATCM were studied and compared to ACCM. The SMC growth 
promoting activity of ATCM was partly reduced by heat (Fig. 5). The remaining 
activity of ATCM after heating was resistant to trypsin but partly sensitive to 
proteinase K, suggesting that the proteinous component produced by cultured mature 
adipocytes is also present in ATCM. It is important to notice that about 40% of the 
biological activity of ATCM are still observed after heating and proteinase K 
treatment (Fig. 5B), suggesting a non-proteinous component produced from peri-
vascular tissue. It is not surprising to observe a more complex feature of ATCM than 
that of ACCM, since peri-vascular adipose tissue contains heterogeneous cell types 
such as endothelial cells, fibroblasts, mesenchymal stromal cells, etc. It remains for 
future studies to analyze the individual components released by the different cells in 
the peri-vascular adipose tissues under physiological and pathological conditions.      
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Nonetheless, the sum effect of peri-vascular adipose tissue on SMC growth 
was investigated in aging and obesity animal models. The results showed that the 
growth promoting effect of peri-aortic adipose tissue was significantly enhanced in 
aged rats (Fig. 6A), suggesting that it might be involved in age-associated vascular 
intimal thickening or remodeling(16), although this effect appears modest under our 
in vitro experimental conditions. One could presume that during the chronic aging 
process which is associated with increased absolute fat mass deposition around blood 
vessels (table 1) and deterioration of vascular protective mechanisms such as 
endothelial functions(16), the growth promoting effect of perivascular adipose tissue 
could become dominant and promote negative vascular remodeling and vascular 
diseases.
The impact of obesity on perivascular adipose tissue-induced SMC growth 
was studied in two obesity models. In the genetic obese Zucker fa/fa rats deficient in 
leptin receptors, the growth promoting effect of perivascular adipose tissue, to our 
surprise, was less pronounced (Fig. 6C). In contrast, in the high fat diet induced obese 
WKY rats, the SMC growth promoting effect of peri-aortic fat was significantly 
increased as compared to the control group (Fig. 6B). In both obesity models, the 
amount of peri-aortic fat is almost twice as much in the obese than in the lean rats, the 
ratio of peri-aortic fat/body weight is higher in the obese than in the lean rats (i.e. 
perivascular fat mass increases proportionally more than body weight in the obesity, 
see table 1). It is presumable that the SMC growth stimulating effect of perivascular 
adipose tissue might become even more important in obesity, in particular, when 
adipocyte-derived growth promoters such as leptin and TNFD are increased and 
growth inhibitors such as adiponectin are decreased(13; 24).
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The contrasting results between the two obesity models might be due to the 
fact that in the obese Zucker fa/fa rats, there is no effect of leptin due to leptin 
receptor deficiency. Leptin has been shown to be associated with increase in 
cardiovascular risk (5). It is also to notice that the genetic obese Zucker fa/fa rats are 
relatively resistant to atherosclerosis and changes in vascular functions(1; 3; 34). 
Also, the production of the newly suggested relaxing factor(s) released from peri-
aortic adipose tissue in Zucker fa/fa rats remains preserved as demonstrated recently 
(18). Interestingly, in high fat diet-induced obese WKY rats, a more relevant obesity 
model, the SMC growth stimulating effect of perivascular adipose tissue conditioned 
medium was significantly enhanced as compared to the lean controls (Fig. 6B),
implicating a more pronounced release of SMC growth factors from perivascular 
adipose tissue of the obese rats. 
In conclusion, our study suggests that mature adipocytes release a hydrosoluble 
protein growth factor(s) with a molecular weight >100 kDa for SMC. Perivascular 
adipose tissue stimulates SMC proliferation, which is enhanced in aged WKY and in 
high fat diet-induced obesity. This adipocyte-derived growth factor(s) and the effect 
of perivascular adipose tissue may be involved in vascular disease associated with 
aging and obesity. 
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Figure legends 
Fig. 1: Adipocyte-conditioned medium (ACCM) stimulates SMC proliferation. 
ACCM of differentiated (but not premature) 3T3-L1 adipocytes (24-hour 
conditioning) concentration-dependently stimulated SMC proliferation (48-hour 
stimulation) either from human saphenous vein (panel A) or aorta (panel B). The 
growth promoting effect of ACCM in the venous SMC was abolished by charcoal 
treatment (panel C). *p<0.05 and **p<0.01 vs. control i.e. cells not treated with 
ACCM; §p<0.01 vs. cells treated with ACCM alone. 
Fig. 2: SMC proliferation stimulated by adipocyte-conditioned medium (ACCM) 
is heat- and trypsin-resistant. Neither cell proliferation (panel A) nor increase in cell 
number (panel B) stimulated by ACCM (100 Pl/ml, 24-hour conditioning) of mature 
adipocytes over 8 days was affected by treatment of ACCM by heating (65°C, 10 
minutes) or trypsin (2 Pg/ml, 37°C, 2 hours), whereas p42/44mapk activation 
(phosphorylation at Thr202/Tyr204) stimulated by ACCM (100 Pl/ml, 10 minutes) was 
strongly attenuated by the treatments (panel C). *p<0.05 and **p<0.01 vs. control; 
§p<0.05 and §§p<0.01 vs. cells treated by ACCM alone. 
Fig. 3: Treatment of adipocyte conditioned medium (ACCM) with proteinase K 
(PK, 10 Pg/ml, 37°C, 2 hours) abolishes its growth promoting effect. The SMC 
growth promoting effect of ACCM was only slightly reduced by heating at a higher 
temperature i.e. 90°C for 30 minutes, a condition which is required to inactivate PK. 
The effect of ACCM was, however, further abolished by PK treatment. **p<0.01 vs. 
control; #p<0.05 and ##p<0.01 vs. ACCM; §p<0.05 vs. heated ACCM. 
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Fig. 4: The growth factor(s) released from cultured adipocytes is hydrosoluble 
and has a molecular weight higher than 100 kDa. (Panel A) Ultrafiltration of 
heated and trypsinized (h+t) ACCM with a membrane with molecular weight cut-off 
at 100 kDa showed that the growth promoting effect was retained in the fraction 
which has a molecular weight >100 kDa. (Panel B) Lipid extraction of heated and 
trypsinized (h+t) ACCM with butanol showed that the growth stimulating activity of 
ACCM was retained in the hydrosoluble fraction. *p<0.05 and **p<0.01 vs. control; 
#p<0.05 vs. heated and trypsinized (h+t) ACCM. Hydro = hydrosoluble and lipo = 
liposoluble.
Fig. 5: The growth promoting effect of periaortic adipose tissue conditioned 
medium (ATCM) is trypsin-resistant, but proteinase K- and heat-sensitive. (A)
SMC proliferation stimulated by ATCM was slightly but significantly reduced by 
heating (65°C, 10 minutes) but not by trypsin treatment (2 Pl/ml, 37°C, 2 hours). (B) 
SMC proliferation stimulated by ATCM was significantly reduced by heating (90°C, 
30 minutes) and further by proteinase K treatment (PK, 10 Pg/ml, 37°C, 2 hours). 
*p<0.05 and **p<0.01 vs. control; ##p<0.01 vs. cells treated by ATCM alone; 
§p<0.05 vs. heated ATCM-treated cells. 
Fig. 6: Effects of peri-aortic adipose tissue conditioned medium (ATCM) on 
SMC growth in aging and obesity. ATCM stimulated SMC proliferation, which was 
significantly enhanced in aged (panel A) and obese (panel B) WKY rats, but 
decreased in obese Zucker fa/fa rats (panel C). *p<0.05 and **p<0.01 vs. control; 
§p<0.05 and §§p<0.01 young vs. old rats and lean vs. obese rats at the same 
concentration of ATCM. 
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Table1. Body weight and perivascular fat in aging and obesity 
WKY rats Zucker rats 
young old lean obese lean obese
Body weight (g) 339±12 469±13** 343±3 442±11†† 330±5 451±19††
Perivascular fat 
weight (g) 
0.4±0.1 0.6±0.1 0.5±0.3 0.8±0.1†† 0.4±0.05 0.8±0.01††
Perivascular fat/body 
weight (x10-3)
1.1±0.1 1.2±0.1 1.3±0.1 1.9±0.2 1.3±0.1 1.8±0.06†
Values are means±SEM, n=3/group. **p<0.01 vs. young; ††p<0.01 and †p<0.05 vs. lean. 
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